Clinical implications of PTEN loss in prostate cancer (2018)
Source: Nature Reviews Urology. Unidade: FMRP
Subjects: PRÓSTATA, NEOPLASIAS, BIOMARCADORES, GENÉTICA MÉDICA
ABNT
JAMASPISHVILI, Tamara et al. Clinical implications of PTEN loss in prostate cancer. Nature Reviews Urology, v. 15, n. 4, p. 222–234, 2018Tradução . . Disponível em: https://doi.org/10.1038/nrurol.2018.9. Acesso em: 27 set. 2024.APA
Jamaspishvili, T., Berman, D. M., Ross, A. E., Scher, H. I., Marzo, A. M. D., Squire, J. A., & Lotan, T. L. (2018). Clinical implications of PTEN loss in prostate cancer. Nature Reviews Urology, 15( 4), 222–234. doi:10.1038/nrurol.2018.9NLM
Jamaspishvili T, Berman DM, Ross AE, Scher HI, Marzo AMD, Squire JA, Lotan TL. Clinical implications of PTEN loss in prostate cancer [Internet]. Nature Reviews Urology. 2018 ; 15( 4): 222–234.[citado 2024 set. 27 ] Available from: https://doi.org/10.1038/nrurol.2018.9Vancouver
Jamaspishvili T, Berman DM, Ross AE, Scher HI, Marzo AMD, Squire JA, Lotan TL. Clinical implications of PTEN loss in prostate cancer [Internet]. Nature Reviews Urology. 2018 ; 15( 4): 222–234.[citado 2024 set. 27 ] Available from: https://doi.org/10.1038/nrurol.2018.9